BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan MC, Marra CA, Sadatsafavi M, Marra F, Morán-Mendoza O, Moadebi S, Elwood RK, FitzGerald JM. Cost-effectiveness of LTBI treatment for TB contacts in British Columbia. Value Health 2008;11:842-52. [PMID: 18489519 DOI: 10.1111/j.1524-4733.2008.00334.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Pépin J, Desjardins F, Carignan A, Lambert M, Vaillancourt I, Labrie C, Mercier D, Bourque R, Leblanc L. Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada. PLoS ONE 2022;17:e0267781. [DOI: 10.1371/journal.pone.0267781] [Reference Citation Analysis]
2 Mugwagwa T, Abubakar I, White PJ. Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling. Thorax 2021;76:281-91. [PMID: 33542086 DOI: 10.1136/thoraxjnl-2019-214004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Alsdurf H, Oxlade O, Adjobimey M, Ahmad Khan F, Bastos M, Bedingfield N, Benedetti A, Boafo D, Buu TN, Chiang L, Cook V, Fisher D, Fox GJ, Fregonese F, Hadisoemarto P, Johnston JC, Kassa F, Long R, Moayedi Nia S, Nguyen TA, Obeng J, Paulsen C, Romanowski K, Ruslami R, Schwartzman K, Sohn H, Strumpf E, Trajman A, Valiquette C, Yaha L, Menzies D. Resource implications of the latent tuberculosis cascade of care: a time and motion study in five countries. BMC Health Serv Res 2020;20:341. [PMID: 32316963 DOI: 10.1186/s12913-020-05220-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Campbell JR, Johnston JC, Cook VJ, Sadatsafavi M, Elwood RK, Marra F. Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries. Emerg Infect Dis 2019;25:661-71. [PMID: 30882302 DOI: 10.3201/eid2504.171630] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
5 Cavany SM, Vynnycky E, Anderson CS, Maguire H, Sandmann F, Thomas HL, White RG, Sumner T. Should NICE reconsider the 2016 UK guidelines on TB contact tracing? A cost-effectiveness analysis of contact investigations in London. Thorax 2019;74:185-93. [PMID: 30121574 DOI: 10.1136/thoraxjnl-2018-211662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Campbell JR, Johnston JC, Sadatsafavi M, Cook VJ, Elwood RK, Marra F. Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada. PLoS One 2017;12:e0186778. [PMID: 29084227 DOI: 10.1371/journal.pone.0186778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Patel AR, Campbell JR, Sadatsafavi M, Marra F, Johnston JC, Smillie K, Lester RT. Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study. BMJ Open 2017;7:e015108. [PMID: 28918407 DOI: 10.1136/bmjopen-2016-015108] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
8 Herráez Ó, Asencio-egea MÁ, Huertas-vaquero M, Carranza-gonzález R, Castellanos-monedero J, Franco-huerta M, Barberá-farré JR, Tenías-burillo JM. Cost-effectiveness study of the microbiological diagnosis of tuberculosis using geneXpert MTB/RIF®. Enfermedades infecciosas y microbiologia clinica (English ed ) 2017;35:403-410. [DOI: 10.1016/j.eimce.2017.06.007] [Reference Citation Analysis]
9 Herráez Ó, Asencio-Egea MÁ, Huertas-Vaquero M, Carranza-González R, Castellanos-Monedero J, Franco-Huerta M, Barberá-Farré JR, Tenías-Burillo JM. Cost-effectiveness study of the microbiological diagnosis of tuberculosis using geneXpert MTB/RIF®. Enferm Infecc Microbiol Clin 2017;35:403-10. [PMID: 27445177 DOI: 10.1016/j.eimc.2016.06.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
10 Hughes R, Wonderling D, Li B, Higgins B. The cost effectiveness of Nucleic Acid Amplification Techniques for the diagnosis of tuberculosis. Respir Med 2012;106:300-7. [PMID: 22137190 DOI: 10.1016/j.rmed.2011.10.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
11 Chavan S, Newlands D, Smith C. A systematic review of economic evaluations of chemoprophylaxis for tuberculosis. J Trop Med 2011;2011:130976. [PMID: 22131996 DOI: 10.1155/2011/130976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]